| Literature DB >> 29765335 |
Lucia Billeci1, Alessandro Tonacci1, Antonio Narzisi2, Zaira Manigrasso3, Maurizio Varanini1, Francesca Fulceri2, Caterina Lattarulo4, Sara Calderoni2,5, Filippo Muratori2,5.
Abstract
Background: Autism Spectrum Disorders (ASD) are a heterogeneous group of neurodevelopmental disorders featuring early impairments in social domain, with autonomic nervous system (ANS) unbalance possibly representing a useful marker for such disturbances. Impairments in joint attention (JA) are one of the earliest markers of social deficits in ASD. In this study, we assessed the feasibility of using wearable technologies for characterizing the ANS response in ASD toddlers during the presentation of JA stimuli.Entities:
Keywords: autism spectrum disorders; autonomic nervous system; eye-tracking; joint attention; wearable sensors
Year: 2018 PMID: 29765335 PMCID: PMC5938714 DOI: 10.3389/fphys.2018.00467
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Distribution of Griffith Performance for ASD and TD groups.
Study population (significance: p < 0.05).
| 20 | 20 | 1.00 | |
| Age (months, mean ± SD) | 26.1 ± 3.3 | 26.2 ± 3.7 | 0.48 |
| Gender (M/F) | 14/6 | 15/5 | 0.80 |
| Griffith Performance (mean ± SD) | 81.9 ± 21.8 | 108.9 ± 19.6 | 0.001 |
| ADOS-G, module 1– | 14.9 ± 4.5 | – | – |
| ADOS-G, module 1– | 4.9 ± 2 | – | – |
| ADOS-G, module 1– | 9.8 ± 3.4 | – | – |
| ADOS-G, module 1– | 7.3 ± 2.1 | – | – |
Figure 2LF changes between phases (baseline and task) in ASD (blue) and TD (red) groups. Median and interquartile are reported.
Comparison between the two study groups in all the single ECG features extracted in the single testing phases (significance: p < 0.05).
| HR (bpm, mean ± SD) | 104.24 ± 36.41 | 112.49 ± 22.82 | 0.41 |
| SDNN (ms, mean ± SD) | 0.45 ± 0.63 | 0.14 ± 0.16 | 0.04 |
| CV (n.u., mean ± SD) | 0.78 ± 0.80 | 0.28 ± 0.32 | 0.021 |
| pNN10 (%, mean ± SD) | 74.21 ± 23.53 | 68.57 ± 24.57 | 0.49 |
| LFn (n.u., mean ± SD) | 0.43 ± 0.19 | 0.38 ± 0.16 | 0.59 |
| HFn (n.u., mean ± SD) | 0.57 ± 0.10 | 0.62 ± 0.08 | 0.95 |
| LF/HF Ratio (mean ± SD) | 3.81 ± 1.91 | 4.67 ± 2.04 | 0.26 |
| LF [ms2, median (IQR)] | 696.00 (1669.00) | 316.00 (1162.00) | 0.047 |
| HF [ms2, median (IQR)] | 1550.00 (3746.00) | 344.50 (2587.00) | 0.34 |
| HR (bpm, mean ± SD) | 119.06 ± 43.53 | 120.56 ± 25.43 | 0.90 |
| SDNN (ms, mean ± SD) | 0.26 ± 0.32 | 0.15 ± 0.22 | 0.03 |
| CV (n.u., mean ± SD) | 0.53 ± 0.44 | 0.30 ± 0.35 | 0.09 |
| pNNx (%, mean ± SD) | 75.24 ± 19.55 | 68.01 ± 19.66 | 0.28 |
| LFn (n.u., mean ± SD) | 0.32 ± 0.21 | 0.41 ± 0.19 | 0.24 |
| HFn (n.u., mean ± SD) | 0.68 ± 0.44 | 0.59 ± 0.19 | 0.24 |
| LF/HF Ratio (mean ± SD) | 2.86 ± 2.12 | 3.33 ± 1.91 | 0.50 |
| LF [ms2, median (IQR)] | 318.00 (1669.0) | 537.00 (1199.30) | 0.50 |
| HF [ms2, median (IQR)] | 1300.00 (2738.00) | 472.50 (3110.50) | 0.91 |
For variables with normal distribution mean and standard deviation (SD) is reported, while for variables with non-normal distributions median and interquartile range (IQR) is reported. n.u.: normalized units.